What is VeraDermics, Inc (MANE)?
VeraDermics, Inc is a biotechnology company engaged in the development of dermatological products and therapies. The company focuses on innovative treatments for skin conditions, leveraging advances in molecular biology and pharmaceutical sciences. VeraDermics aims to address unmet medical needs in dermatology through research and development of topical and systemic therapies. Its product pipeline includes candidates targeting inflammatory, autoimmune, and other skin-related disorders. Operating within the pharmaceutical and biotech sectors, VeraDermics collaborates with scientific institutions and clinical partners to advance its therapeutic programs. The company emphasizes the application of novel mechanisms of action to improve efficacy and safety profiles. VeraDermics contributes to the broader field of dermatological healthcare by pursuing solutions that enhance patient quality of life.
VeraDermics, Inc Stock Price Today: Live Overview
The price today is shaped by the market's current movements, with Once Upon a Farm, PBC trading between $55.95 and $61.91. It is currently priced at $62.52, reflecting a daily change of +5.9936%.
FAQ: VeraDermics, Inc (MANE)
What is the current price of MANE stock?
The current price stands at $62.52.
Does MANE pay dividends?
VeraDermics, Inc does not pay dividends.
Does MANE have a formal corporate presence or regional headquarters in the UAE?
VeraDermics, Inc operates through partners in the UAE and has no official regional office or subsidiary.
What is MANE best known for?
VeraDermics, Inc is most famous for developing dermatology-related products.
What assets are typically shown together with MANE?
Commonly shown alongside MANE: Global X Cybersecurity ETF, Global X NASDAQ 100 Covered Call ETF, First Trust IndXX NextG ETF
Latest shares articles



